First Mercantile Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $84K | Buy |
+296
| New | +$97K | 0.01% | 707 |
|
|
2020
Q4 | – | Sell |
-1,075
| Closed | -$254K | – | 854 |
|
|
2020
Q3 | $254K | Sell |
1,075
-275
| -20% | -$76.7K | 0.03% | 318 |
|
|
2020
Q2 | $361K | Sell |
1,350
-1,210
| -47% | -$364K | 0.05% | 239 |
|
|
2020
Q1 | $809K | Sell |
2,560
-24
| -0.9% | -$7.28K | 0.12% | 94 |
|
|
2019
Q4 | $767K | Sell |
2,584
-2,212
| -46% | -$614K | 0.09% | 137 |
|
|
2019
Q3 | $1.12M | Buy |
4,796
+23
| +0.5% | +$5.36K | 0.12% | 92 |
|
|
2019
Q2 | $1.12M | Sell |
4,773
-644
| -12% | -$149K | 0.12% | 95 |
|
|
2019
Q1 | $1.28M | Sell |
5,417
-2,623
| -33% | -$826K | 0.3% | 69 |
|
|
2018
Q4 | $2.42M | Sell |
8,040
-551
| -6% | -$176K | 0.59% | 31 |
|
|
2018
Q3 | $3.04M | Buy |
8,591
+492
| +6% | +$169K | 0.6% | 31 |
|
|
2018
Q2 | $2.35M | Buy |
8,099
+864
| +12% | +$243K | 0.47% | 38 |
|
|
2018
Q1 | $1.98M | Sell |
7,235
-742
| -9% | -$230K | 0.41% | 45 |
|
|
2017
Q4 | $2.54M | Sell |
7,977
-1,506
| -16% | -$483K | 0.5% | 42 |
|
|
2017
Q3 | $2.97M | Buy |
9,483
+3,781
| +66% | +$1.12M | 0.54% | 35 |
|
|
2017
Q2 | $1.55M | Sell |
5,702
-2,544
| -31% | -$673K | 0.28% | 72 |
|
|
2017
Q1 | $2.25M | Sell |
8,246
-892
| -10% | -$252K | 0.34% | 62 |
|
|
2016
Q4 | $2.59M | Sell |
9,138
-934
| -9% | -$277K | 0.4% | 55 |
|
|
2016
Q3 | $3.15M | Sell |
10,072
-1,362
| -12% | -$403K | 0.42% | 50 |
|
|
2016
Q2 | $2.77M | Sell |
11,434
-293
| -2% | -$77.2K | 0.34% | 66 |
|
|
2016
Q1 | $3.05M | Buy |
11,727
+251
| +2% | +$66.3K | 0.37% | 64 |
|
|
2015
Q4 | $3.52M | Buy |
11,476
+668
| +6% | +$192K | 0.36% | 65 |
|
|
2015
Q3 | $3.15M | Buy |
10,808
+1,044
| +11% | +$345K | 0.32% | 72 |
|
|
2015
Q2 | $3.94M | Buy |
9,764
+3,421
| +54% | +$1.37M | 0.34% | 63 |
|
|
2015
Q1 | $2.68M | Buy |
6,343
+5,032
| +384% | +$1.98M | 0.22% | 104 |
|
|
2014
Q4 | $445K | Buy |
1,311
+1,091
| +496% | +$353K | 0.04% | 533 |
|
|
2014
Q3 | $73K | Hold |
220
| – | – | 0.01% | 947 |
|
|
2014
Q2 | $69K | Sell |
220
-3,286
| -94% | -$989K | 0.01% | 893 |
|
|
2014
Q1 | $1.07M | Sell |
3,506
-1,091
| -24% | -$346K | 0.08% | 346 |
|
|
2013
Q4 | $1.29M | Buy |
4,597
+533
| +13% | +$138K | 0.1% | 286 |
|
|
2013
Q3 | $979K | Buy |
4,064
+2,163
| +114% | +$484K | 0.08% | 379 |
|
|
2013
Q2 | $409K | Buy |
+1,901
| New | +$406K | 0.04% | 594 |
|
Other funds holding BIIB
First Mercantile Trust's BIIB Position: Q3 2021 in Review
First Mercantile Trust opened a new position in Biogen (BIIB) in Q3 2021: 296 shares worth $84K. The stake represents 0.01% of the portfolio and ranks #707 among its holdings. This is a return to the name: First Mercantile Trust previously reported a position in BIIB as recently as Q3 2020.
First Mercantile Trust first reported a position in BIIB in Q2 2013 and has held it in 31 quarters since. The position peaked at $3.94M in Q2 2015. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.
- First Mercantile Trust held 296 shares of Biogen worth $84K as of Q3 2021.
- Biogen was a new First Mercantile Trust position in Q3 2021.
- Biogen made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #707 holding.
- First Mercantile Trust first reported a position in Biogen in Q2 2013 and has held it in 31 quarters since.
- First Mercantile Trust's Biogen position peaked at $3.94M in Q2 2015.
- 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.
Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.